000			01815cam a2200289zu 4500
001			88966169
003			FRCYB88966169
005			20250429184430.0
006			m o d
007			cr un
008			250429s2020 fr | o|||||0|0|||eng d
020			_a9780128200162
035			_aFRCYB88966169
040			_aFR-PaCSA _ben _c _erda
100	1		_aThorat, Nanasaheb D.
245	0	1	_aNanomedicines for Breast Cancer Theranostics _c['Thorat, Nanasaheb D.', 'Bauer, Joanna']
264		1	_bElsevier Science _c2020
300			_a p.
336			_btxt _2rdacontent
337			_bc _2rdamdedia
338			_bc _2rdacarrier
650		0	_a
700	0		_aThorat, Nanasaheb D.
700	0		_aBauer, Joanna
856	4	0	_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88966169 _qtext/html _a
520			_aNanomedicines for Breast Cancer Theranostics addresses the translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspective. The book summarizes research efforts at the preclinical and clinical stage of nanostructures and nanomedicine for dealing with the important challenge of nanomedicine translation in breast cancer theranostics. This book is an important resource for those working in both academia and industry, focusing on hot topics in biomaterials, biomedical engineering, drug delivery and oncology. - Shows how the discovery of new nanomedicines is leading directly to an increase in the early-stage diagnosis of breast cancer - Includes coverage of breast cancer nanomedicine standardization and characterization, highlighting newly developed treatments, diagnostics and treatment monitoring tools - Explains why the design of nanobiomaterials make them effective drug carriers when treating breast cancer
999			_c1331699 _d1331699